cremimycin: isol from Strepromyces sp.MJ635-86F5; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 6449106 |
| MeSH ID | M0289280 |
| Synonym |
|---|
| 182285-29-6 |
| cyclopent(i)azacyclononadecene-7,11,17(8h,12h,19h)-trione, 9,10,13,14,15,16,20,20a-octahydro-19-((2,6-dideoxy-3-o-methylhexopyranosyl)oxy)-15,18-dihydroxy-9-hexyl-2-methyl- |
| cremimycin (antibiotic) |
| cremimycin |
| (2e,4e,6e)-10-hexyl-16,20-dihydroxy-21-(5-hydroxy-4-methoxy-6-methyloxan-2-yl)oxy-3-methyl-9-azabicyclo[17.3.0]docosa-2,4,6,19-tetraene-8,12,18-trione |
Cremimycin is a 19-membered macrolactam glycoside antibiotic based on three distinctive substructures: 1) a β-amino fatty acid starter moiety, 2) a bicyclic macrolacts ring, and 3) a cymarose unit.
| Excerpt | Reference | Relevance |
|---|---|---|
| "Cremimycin is a 19-membered macrolactam glycoside antibiotic based on three distinctive substructures: 1) a β-amino fatty acid starter moiety, 2) a bicyclic macrolactam ring, and 3) a cymarose unit. " | ( A unique amino transfer mechanism for constructing the β-amino fatty acid starter unit in the biosynthesis of the macrolactam antibiotic cremimycin. Amagai, K; Eguchi, T; Kudo, F; Takaku, R, 2013) | 2.04 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||